On This Page

Clinical Fellowships in Autologous Blood and Marrow Transplant, Lymphoma & Myeloma

Program Coordinator: Dr. Anca Prica

Fellows have the opportunity to participate in a clinical fellowship focusing on the treatment of people with cancer using high-dose therapy and autologous and allogeneic stem cell transplantation at the Department of Medical Oncology and Hematology at Princess Margaret.

Fellows are encouraged to prepare manuscripts describing their research. These positions offer a unique opportunity to participate in an active clinical and translational research program.

Contact:

Claudia Scheckmann
UHN Medical Oncology & Hematology Fellowship Administrator
Phone: 416 946 4501 ext. 5429
Email: Claudia.Scheckmann@uhn.ca

Minimum Requirements:

Subspecialty training in hematology and/or medical oncology and be eligible for licensure through the College of Physicians and Surgeons of Ontario.

How to Apply:

Please email a Curriculum Vitae, Letter of Intent, and three Letters of Recommendation to Claudia Scheckmann, Fellowship Administrator.

Clinical Research Fellowship in Allogeneic Blood and Marrow Transplant

Program Coordinator: Dr. Wilson Lam

Fellows have the opportunity to participate in a clinical fellowship focusing on bone marrow transplantation at the Division of Hematology at Princess Margaret Cancer Centre.

This fellowship focuses on clinical management and decision making for patients undergoing allogeneic transplantation for various diseases and their early and long-term management post transplant. Fellows are expected to participate in clinical, research and educational activities. They receive robust exposure to management of complications such as acute and chronic graft versus host disease, infectious issues, and emerging comorbidities such as metabolic disorders and secondary malignancies.

During the fellowship training, fellows are given the opportunity to understand the donor search process, apheresis principles and graft processing including cryopreservation. Knowledge regarding quality control in stem cell transplantation plays a major role during the training process and fellows are exposed to various quality control steps regarding stem cell procurement, infusion and the transplantation process. Strong emphasis is given to ensure that trainees at the completion of this 2-year fellowship program are competent to function as medical experts for allogeneic transplantation and as health advocates, have acquired appropriate managerial skills, and are able to expertly communicate and collaborate within their respective health care environments. Fellows have ample opportunity to participate at various clinical trials, understanding their basic principles and execution. A formal educational program with regular teaching rounds is in place and qualifies for CME credits.

Contact:

Claudia Scheckmann
UHN Medical Oncology & Hematology Fellowship Administrator
Phone: 416 946 4501 ext. 5429
Email: Claudia.Scheckmann@uhn.ca

Minimum Requirements:

Subspecialty training in hematology and/or medical oncology and be eligible for licensure through the College of Physicians and Surgeons of Ontario.

How to Apply:

Please email a Curriculum Vitae, Letter of Intent, and three Letters of Recommendation to Claudia Scheckmann, Fellowship Administrator.

Clinical Research Fellowship in the Drug Development Program/Phase I

Program Coordinator: Dr. Philippe Bedard

Fellows have the opportunity to participate in a clinical research fellowship in drug development at the Department of Medical Oncology at Princess Margaret Cancer Centre.

This fellowship involves active participation in the planning, coordination and implementation of the development of selected protocols mounted by the Drug Development Program at Princess Margaret. Work includes writing protocols and letters of intent; analyzing trial data; presenting results at local, national and international meetings/conferences; and preparing final peer-reviewed manuscripts for publication.

Fellows will be put on the clinical trial patient roster for about one day per week, when they will see patients actively participating in trials run by the Drug Development Program. Work with patients may include such tasks as routine physical examinations and addressing urgent issues.

Contact:

Claudia Scheckmann
UHN Medical Oncology & Hematology Fellowship Administrator
Phone: 416 946 4501 ext. 5429
Email: Claudia.Scheckmann@uhn.ca

Minimum Requirements:

Subspecialty training in hematology and/or medical oncology and be eligible for licensure through the College of Physicians and Surgeons of Ontario.

How to Apply:

Please email a Curriculum Vitae, Letter of Intent, and three Letters of Recommendation to Claudia Scheckmann, Fellowship Administrator.

Clinical Research Fellowship in Medical Oncology

Program Coordinator: Dr. Raymond Jang

Fellows have the opportunity to participate in a clinical research fellowship in medical oncology at the Division of Medical Oncology at Princess Margaret Cancer Centre.

Areas of research and clinical focus are available in one or more of the following disease sites: breast, lung/thoracic, melanoma, neuroendocrine tumours, gastrointestinal, genitourinary, gynecology and sarcoma. Fellows generally focus on one primary disease site. Supervision is provided by one or more of the medical oncology staff. Opportunities to apply for peer-reviewed research funding and graduate degree programs are available and encouraged.

Contact:

Claudia Scheckmann
UHN Medical Oncology & Hematology Fellowship Administrator
Phone: 416 946 4501 ext. 5429
Email: Claudia.Scheckmann@uhn.ca

Minimum Requirements:

Subspecialty training in hematology and/or medical oncology and be eligible for licensure through the College of Physicians and Surgeons of Ontario.

How to Apply:

Please email a Curriculum Vitae, Letter of Intent, and three Letters of Recommendation to Claudia Scheckmann, Fellowship Administrator.​

​​

https://www.uhn.ca/PrincessMargaret/Education/Continuing_Education_Programs/Pages/continuing_education_programs.aspx
Last reviewed: 6/23/2022
Last modified: 11/11/2024 9:10 AM
Back to Top